The following articles are from the John Hopkins University Psilocybin Study run by Dr. Roland Griffiths. They are presented in the order of publication.

Psilocybin can occasion mystical-type experiences having substantial and sustained personal and spiritual significance

Editorial and Commentaries on Article by Griffiths at al.

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significant 14 months later

Human hallucinogen research: Guidelines for safety

Mystical Experiences Occasioned by the Hallucinogen Psilocybin Lead to Increases in the Personality Domain of Openness

This is research headed by Franz Vollenweider in Germany:

Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors

Here is a New Yorker article on the use of psilocybin in treating anxiety in terminal cancer patients:

The Trip Treatment – The New Yorker

Here are two recent articles from Bill Richards, the facilitator and guide for the John Hopkins University psilocybin project subjects:

Abraham Maslow’s Interest in Psychedelic Research: A Tribute

Psychedelic Psychotherapy: Insights from 25 Years of Research”

Lastly, the TED talk presented by Dr. Roland Griffiths on results from psilocybin research:

Dr. Rolland Griffiths on “The Mystical Experience and Psilocybin Research”

Dr. Robin Carhart-Harris describing the neurology of psilocybin: